4D Pharma Research Ltd., a subsidiary of 4D Pharma Plc, is a company headquartered in Aberdeen, UK, that engages in research and experimental development on biotechnology.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Unigen Co., Ltd. is a private company headquartered in the South Korea that manufactures health foods and cosmetics.

Manufactures and distributes pharmaceutical products

Hangzhou Xingao Biotechnology Co., Ltd., established on 2017-05-08, Business scope includes biotechnology,Technology development in the field of medical science and technology,Technical Services,technology transfer,technical consulting;Sales of biological products and pharmaceuticals;Import and export business of goods and technology**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

Ruiwei (Shenzhen) Biotechnology Co., Ltd., established on 2019-12-17, Business scope includes general business items:drug development;Medical R&D and Trial Development;Natural science research and experimental development;Energy Technology Research,Technology Development Services;trade agent;Biotechnology Development Services;Biotechnology Extension Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Domestic Trade;Information Consulting;Operating import and export business.,The licensing program is:none

Reckitt Benckiser (UK) Ltd., a subsidiary of Reckitt Benckiser Group Plc, is a company headquartered in Slough, UK, involved in sanitary paper products.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

The Company has assembled several bioactive technologies, including human and xenotypic monoclonal antibodies of the IgG and IgE class that can induce tumor specific immunity and enhance clinical outcome. Several of the lead components have clinical track records and extensive development dossiers that can be exploited to be integral to combinatorial immunooncology treatment strategies.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Shenghe Biotechnology (Yangzhou) Co., Ltd., established on 2016-09-06, The scope of business includes the production of beverages(protein drinks,Solid beverage,Juice and vegetable juice and its beverages,Tea drinks,other beverages),other food[Fermentation agent for food processing(Lactic acid bacteria powder)series,Whey fermented liquid series,Flavored Milk Fermentation Powder Series(For food processing),Probiotic Fermented Ice Cream Mix(production)series,Probiotic fermented fruit and vegetable powder series(For food processing),Probiotic fermented instant tea powder product series(For food processing)],plant enzymes;Sell ​​self-produced products;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export);Research and development of biological products(Country Restricted,Except prohibited).(The scope of business does not include projects for which the state implements special management measures for foreign investment access,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Lactomason Co. Ltd. is a South Korean company located in Jinju-si. The firm engages in research, development and manufacture of probiotics. It was founded in 2007.

Zhejiang Iseqi Pharmaceutical Technology Co., Ltd., established on 2018-10-15, Business scope includes licensed projects:Cosmetic production;Disinfectant production(Free of Hazardous Chemicals);Production of Class II Medical Devices;Health food production;Health food sales;Technology Import and Export;Import and export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Manufacturing of daily chemical products;Sales of daily chemical products;Maternal and baby products manufacturing;Maternal and baby products sales;Disinfectant sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Conference and Exhibition Services;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).